is the glp-1 patch effective Patches vs. GLP-1 Injections: What You Need to Know Do GLP-1 Patches Really Work?

The goal is not just to become lighter

The capacity of the tri-agonist to prevent the development of spontaneous diabetes compared with the dual incretin GLP-1R/GIPR co-agonist was also tested in mouse models of T2D

True change develops over a longer period, and focusing on your health brings lasting rewards

The reduction of cardiovascular events is not only related to anti-diabetic properties, but also to pleotropic effects leading to the reduction of the residual cardiovascular risk, that has been defined as the risk of progression of CV events (MACE or HF) that remains after the optimal glycaemic control in T2DM patients, and it seems to be related to meta-inflammation, defined as a low-grade chronic and sterile inflammatory status

Even for employers betting that the potential long-term health benefits associated with GLP-1 utilizations and weight loss - including reduced risks for cardiovascular and kidney disease - will ultimately outweigh the substantial upfront costs, those rising upfront costs are becoming problematic